1,710
Participants
Start Date
September 21, 2018
Primary Completion Date
March 15, 2019
Study Completion Date
March 15, 2019
13 Rapid Diagnostic Tests and reference tests
"Rapid diagnostic tests:~1. HCV antibody test (under development); bioLytical Laboratories~2. DPP® HCV (under development); Chembio Diagnostic Systems~3. HCV-Ab Rapid Test; Beijing Wantai Biological Pharmacy Enterprise~4. Rapid Anti-HCV Test; InTec~5. First Response HCV Card Test; Premire Medical Corporation~6. Signal HCV Ver 3.0; Arkray healthcare~7. TRI DOT HCV; J. Mitra \& Co~8. Triplex HIV, HCV, HBsAg; Biosynex SA~9. Standard Q HCV Ab; SD Biosensor~10. HCV Hepatitis Virus Antibody Test; Artron Laboratories~11. SD Bioline HCV; Abbott Diagnostics~12. OraQuick HCV; OraSure~13. Care Start HCV Rapid Test (under development); Access Bio~Reference tests:~Enzyme Immunoassays (EIAs): Murex Anti-HCV EIA version 4.0; Fujirebio Innotest HCV Ab IV~Line Immunoassay (LIA): MP Diagnostics HCV blot 3.0"
Institute of Tropical Medicine, Antwerp
National Center for Disease Control & Public Health/Lugar Center, Tbilisi
Nigerian Institute of Medical Research, Lagos
Collaborators (1)
Institute of Tropical Medicine, Belgium
OTHER
Nigerian Institute of Medical Research
OTHER_GOV
Richard Lugar Centre for Public Health Research, Georgia
UNKNOWN
Foundation for Innovative New Diagnostics, Switzerland
OTHER